Blogs

Michigan lawmakers are pushing a 24% wholesale excise tax on cannabis transfers, on top of existing retail and sales taxes. While projected to raise $420M for infrastructure, this heavy burden could accelerate consolidation, squeezing out small operators and favoring large, integrated firms. Our analysis explores why this tax may reshape Michigan’s cannabis industry.

On August 12, 2025, the U.S. Court of Appeals for the Second Circuit ruled in Variscite NY Four, LLC v. New York State Cannabis Control

The DEA has forwarded a petition to reschedule psilocybin from Schedule I to Schedule II, prompting HHS review. Here’s what this means for businesses, IRS 280E, and the future of the psychedelics industry.

A detailed legal and policy analysis of IRS Code § 280E, its impact on cannabis and psilocybin industries, and the argument that psilocybin should not be treated as a Schedule I or II substance “within the meaning” of the Controlled Substances Act. This article explores tax challenges, legal interpretations, and scientific evidence supporting the rescheduling of psilocybin.

Internal Revenue Code Section 280E is beginning to resemble a dried and brittle leaf, clinging to the branch of antiquated federal law long after the season

Another Case for Challenging 280E: HHS’s Authority and the Collapse of Drug Scheduling Powers The cannabis and psychedelics industries are currently subject to one of